JAMA Oncology Author Interviews podcast

Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in ERBB2-Positive Breast Cancer

0:00
13:01
Rewind 15 seconds
Fast Forward 15 seconds

More episodes from "JAMA Oncology Author Interviews"